Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pre-mRNA processing factor 40 homolog A (PRPF40A) is a protein involved in the early steps of spliceosome assembly by mediating protein-protein interactions necessary for pre-mRNA splicing[1][3][4]. It functions as a scaffold, facilitating the bridge between 5' and 3' splice site recognition, and contains characteristic WW and FF domains that enable the binding of proline-rich motifs in splicing factors such as SF1 and SF3A1[1][4]. PRPF40A contributes to RNA binding, cytoskeleton organization, cell shape, migration, and cytokinesis, with additional roles in regulating alternative splicing and transcription[3][5]. It is associated with pathways and diseases involving mRNA processing defects, such as gastric cancer and Rett syndrome[3]. No drugs are currently known to target PRPF40A directly, nor is it established as a therapeutic target, but its roles in gene expression regulation and disease pathogenesis make it of biological interest[3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pre-mRNA processing factor 40 homolog A (PRPF40A).